Assessment of Response to a Third Dose of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Patients with Solid Tumors Undergoing Active Treatment

Yakir Rottenberg; Albert Grinshpun; Iddo Z. Ben-Dov; Esther Oiknine Djian; Dana G. Wolf; Luna Kadouri

doi:10.1001/jamaoncol.2021.6764

Assessment of Response to a Third Dose of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Patients with Solid Tumors Undergoing Active Treatment

Yakir Rottenberg
, Albert Grinshpun^*
, Iddo Z. Ben-Dov
, Esther Oiknine Djian
, Dana G. Wolf
, Luna Kadouri

^*Corresponding author for this work

Institute for Medical Research Israel-Canada (IMRIC)

Research output: Contribution to journal › Letter › peer-review

36 Scopus citations

Abstract

This cohort study evaluates the short-term humoral response to a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients undergoing acute systemic therapy for solid tumors.

Original language	English
Pages (from-to)	300-301
Number of pages	2
Journal	JAMA Oncology
Volume	8
Issue number	2
DOIs	https://doi.org/10.1001/jamaoncol.2021.6764
State	Published - Feb 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1001/jamaoncol.2021.6764

Cite this

@article{2db3f97eb2cb4bcda92e4bcc63fee2c0,

title = "Assessment of Response to a Third Dose of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Patients with Solid Tumors Undergoing Active Treatment",

abstract = "This cohort study evaluates the short-term humoral response to a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients undergoing acute systemic therapy for solid tumors.",

author = "Yakir Rottenberg and Albert Grinshpun and Ben-Dov, \{Iddo Z.\} and \{Oiknine Djian\}, Esther and Wolf, \{Dana G.\} and Luna Kadouri",

year = "2022",

month = feb,

doi = "10.1001/jamaoncol.2021.6764",

language = "אנגלית",

volume = "8",

pages = "300--301",

journal = "JAMA Oncology",

issn = "2374-2437",

publisher = "American Medical Association",

number = "2",

}

TY - JOUR

T1 - Assessment of Response to a Third Dose of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Patients with Solid Tumors Undergoing Active Treatment

AU - Rottenberg, Yakir

AU - Grinshpun, Albert

AU - Ben-Dov, Iddo Z.

AU - Oiknine Djian, Esther

AU - Wolf, Dana G.

AU - Kadouri, Luna

PY - 2022/2

Y1 - 2022/2

N2 - This cohort study evaluates the short-term humoral response to a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients undergoing acute systemic therapy for solid tumors.

AB - This cohort study evaluates the short-term humoral response to a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients undergoing acute systemic therapy for solid tumors.

UR - https://www.scopus.com/pages/publications/85120058939

U2 - 10.1001/jamaoncol.2021.6764

DO - 10.1001/jamaoncol.2021.6764

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 34812840

AN - SCOPUS:85120058939

SN - 2374-2437

VL - 8

SP - 300

EP - 301

JO - JAMA Oncology

JF - JAMA Oncology

IS - 2

ER -

Assessment of Response to a Third Dose of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Patients with Solid Tumors Undergoing Active Treatment

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this